ES2166048T3 - Mercaptocetonas y mercaptoalcoholes, un procedimiento para su preparacion y su utilizacion como inhibidores de las metaloproteinasas matriciales. - Google Patents

Mercaptocetonas y mercaptoalcoholes, un procedimiento para su preparacion y su utilizacion como inhibidores de las metaloproteinasas matriciales.

Info

Publication number
ES2166048T3
ES2166048T3 ES97305020T ES97305020T ES2166048T3 ES 2166048 T3 ES2166048 T3 ES 2166048T3 ES 97305020 T ES97305020 T ES 97305020T ES 97305020 T ES97305020 T ES 97305020T ES 2166048 T3 ES2166048 T3 ES 2166048T3
Authority
ES
Spain
Prior art keywords
sub
arilo
sup
mercaptoalcoholes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97305020T
Other languages
English (en)
Inventor
Jeremy Ian Levin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2166048T3 publication Critical patent/ES2166048T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Pyridine Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Furan Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A COMPUESTOS INHIBIDORES DE METALOPROTEINASA DE MATRIZ DE FORMULA: EN LOS QUE R{SUP,1} ES ALQUILO C{SUB,1} CIONALMENTE POR HALOGENO, HIDROXI, ALCOXI C{SUB,1} AMINO, CARBOXILO, ALCOXICARBONILO C{SUB,1} MIDO, NITRILO, MONOO, ALQUILTIO C{SUB,1} C{SUB,6}, ARILO, ,2}ARILO, DONDE ARILO ESTA OPCIONALMENTE SUSTITUIDO CON ALQUILO C{SUB,1} OGENO, CIANO, NITRO, CARBOXAMIDO O HIDROXI; Y ALCANOSULFONILOXI C{SUB,1} P,6} ES H O R{SUP,2} Y R{SUP,6} CONJUNTAMENTE SON CARBONILO; LOS INTERMEDIARIOS QUIMICOS; Y PROCESOS PARA LA PREPARACION DE ESTOS COMPUESTOS Y SUS INTERMEDIARIOS. LAS METALOPROTEINASAS DE MATRIZ (MMP) SON UNA FAMILIA DE PROTEINASAS DEPENDIENTES DE CALCIO QUE CONTIENEN CINC, E INCLUYEN ESTROMALISINAS, COLAGENASAS Y GELATINASAS. ESTOS ENZIMAS MMP SON CAPACES DE DEGRADAR LOS COMPONENTES PROTEICOS DEL TEJIDO CONJUNTIVO Y PARECEN ESTAR IMPLICADOS EN EL REMODELADO TISULAR, ESTO ES, CICATRIZACION DE HERIDAS Y RECAMBIO DEL TEJIDO CONJUNTIVO. DE FORMA INESPERADA, LOS MERCAPTOALCOHOLES CON CONFIGURACION S EN EL CARBONO PORTADOR DE HIDROXILO HAN DEMOSTRADO SER AL MENOS 4 VECES MAS POTENTES QUE LOS (R) ALCOHOLES ANALOGOS TANTO IN VITRO COMO IN VIVO PARA INHIBIR LOS ENZIMAS MMP.
ES97305020T 1996-07-10 1997-07-09 Mercaptocetonas y mercaptoalcoholes, un procedimiento para su preparacion y su utilizacion como inhibidores de las metaloproteinasas matriciales. Expired - Lifetime ES2166048T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67799496A 1996-07-10 1996-07-10

Publications (1)

Publication Number Publication Date
ES2166048T3 true ES2166048T3 (es) 2002-04-01

Family

ID=24720941

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97305020T Expired - Lifetime ES2166048T3 (es) 1996-07-10 1997-07-09 Mercaptocetonas y mercaptoalcoholes, un procedimiento para su preparacion y su utilizacion como inhibidores de las metaloproteinasas matriciales.

Country Status (21)

Country Link
EP (1) EP0818443B1 (es)
JP (1) JPH1067737A (es)
KR (1) KR980009233A (es)
CN (1) CN1336367A (es)
AT (1) ATE210113T1 (es)
AU (1) AU731155B2 (es)
BR (1) BR9703800A (es)
CA (1) CA2208676A1 (es)
CZ (1) CZ202597A3 (es)
DE (1) DE69708770T2 (es)
DK (1) DK0818443T3 (es)
ES (1) ES2166048T3 (es)
HK (1) HK1008215A1 (es)
HU (1) HUP9701127A3 (es)
IL (1) IL121125A0 (es)
NO (1) NO308597B1 (es)
NZ (1) NZ328288A (es)
PT (1) PT818443E (es)
SK (1) SK88597A3 (es)
TW (1) TW424083B (es)
ZA (1) ZA976121B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5292193A (en) * 1992-10-02 1994-04-26 Merck & Co., Inc. N-(mercaptoacyl)peptidyl derivatives as antidegenerative agents
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
US5831004A (en) * 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use

Also Published As

Publication number Publication date
EP0818443B1 (en) 2001-12-05
DE69708770D1 (de) 2002-01-17
DE69708770T2 (de) 2002-08-08
EP0818443A3 (en) 1998-08-19
NO308597B1 (no) 2000-10-02
NO973004D0 (no) 1997-06-27
DK0818443T3 (da) 2002-04-02
HK1008215A1 (en) 1999-05-07
AU731155B2 (en) 2001-03-22
ATE210113T1 (de) 2001-12-15
CZ202597A3 (cs) 1998-09-16
BR9703800A (pt) 1998-08-18
ZA976121B (en) 1999-01-11
JPH1067737A (ja) 1998-03-10
CA2208676A1 (en) 1998-01-10
CN1336367A (zh) 2002-02-20
IL121125A0 (en) 1997-11-20
KR980009233A (ko) 1998-04-30
NO973004L (no) 1998-01-12
NZ328288A (en) 1999-01-28
PT818443E (pt) 2002-05-31
HUP9701127A3 (en) 2000-08-28
HU9701127D0 (en) 1997-08-28
SK88597A3 (en) 1998-01-14
EP0818443A2 (en) 1998-01-14
TW424083B (en) 2001-03-01
AU2857197A (en) 1998-01-22
HUP9701127A2 (hu) 1999-02-01

Similar Documents

Publication Publication Date Title
CR20120007A (es) 2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728)
ES2183937T3 (es) Inhibidores de la adhesion celular.
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
ES2045110T3 (es) Mejoras en o relacionadas con antagonistas de leucotrienos.
ES2196502T3 (es) Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas.
BR9901279A (pt) Triciclicos substituìdos
BR0013966A (pt) Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
ATE233552T1 (de) Thiol-sulfonen als metalloproteinaseinhibitoren
GT199900029A (es) Compuestos heterociclicos como inhibidores de enzimas rotamasas.
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
BR9712285A (pt) Tetrafosfonato bicìclico de trianidridas
HU9903732D0 (en) Treatment of bph with cgmp elevators
ES2189993T3 (es) Sulfamidas de aminoacilo para el tratamiento de trastornos hiperproliferativos.
TR199801582T2 (xx) Bakteri �ld�r�c� ve mantar �ld�r�c� peptit.
HUP0200157A2 (hu) A terméketlenség kezelése
ES2166048T3 (es) Mercaptocetonas y mercaptoalcoholes, un procedimiento para su preparacion y su utilizacion como inhibidores de las metaloproteinasas matriciales.
ES2193197T3 (es) Craquizacion catalitica com mcm-49.
NO20006506D0 (no) Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
AR026895A1 (es) Promotor del crecimiento de los animales, y metodo para promover el crecimiento de los animales
ITMI991318A0 (it) Procedimento per la preparazione di aromatici idrossilati con idrogeno e ossigeno
HK1096423A1 (en) Isolated luciferases and the use thereof
ATE250580T1 (de) Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie
ES2098186B1 (es) Composiciones farmaceuticas a base de aminometilindoles para su aplicacion terapeutica como neuroprotectores en las enfermedades de parkinson y alzheimer.
ES2174573T3 (es) Procedimientos de identificacion de substancias para la inhibicion de las lesiones neoplasticas.
ES2091124T3 (es) Alilamino-nitroaromatos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 818443

Country of ref document: ES